Searchable abstracts of presentations at key conferences in endocrinology

ea0050p395 | Thyroid | SFEBES2017

Recent liothyronine price increases have changed primary care prescription practice, with increased referrals to specialist care

Terry Isabelle , Perros Petros , Moran Carla

Background: The cost of liothyronine (T3) has significantly increased, possibly affecting prescription practices.Methods: An online questionnaire was designed to assess current T3 use by UK endocrinologists and to determine whether the price increase resulted in a change in primary care prescription practices. Consultant grade members of the Society for Endocrinology Thyroid Network were invited to partake.Results: Re...

ea0050p395 | Thyroid | SFEBES2017

Recent liothyronine price increases have changed primary care prescription practice, with increased referrals to specialist care

Terry Isabelle , Perros Petros , Moran Carla

Background: The cost of liothyronine (T3) has significantly increased, possibly affecting prescription practices.Methods: An online questionnaire was designed to assess current T3 use by UK endocrinologists and to determine whether the price increase resulted in a change in primary care prescription practices. Consultant grade members of the Society for Endocrinology Thyroid Network were invited to partake.Results: Re...

ea0031p338 | Steroids | SFEBES2013

A ‘Heavy’ price of beauty therapy

Rashid Nazia , Teng Chung Teng

Introduction: Iatrogenic Cushing’s syndrome from potent topical steroid use, resulting in suppression of the hypothalamic-pituitary-adrenal axis is well recognised. However, this may not be well acknowledged in amongst a general medical take. We report a case of Cushing’s syndrome from long term use of skin whitening cream and topical steroids, highlighting the importance of detailed history taking.Case history: A 49-year-old Nigerian female wa...

ea0047oc3 | Spotlight on Neuroendocrine tumours | Theranostics2016

Optimised production of 64Cu-SARTATE for a phase 1 clinical trial

Roselt Peter , Noonan Wayne , Jeffery Charmaine , Price Roger , Hedt Amos

A new radiopharmaceutical using the somatostatin analogue octreotide has been developed for use in humans. SARTATE consists of the novel bifunctional chelator, MeCOSar, conjugated to (Tyr3)-octreotate. MeCOSar is a superior chelator for copper over a wide pH range and at room temperature, which allows for SARTATE to be used as an imaging/therapy pair when radiolabelled with copper-64 and copper-67.4Cu-SARTATE was produced by radiola...

ea0033dp5 | Diabetes Professionals Meeting Programme | BSPED2013

Kids in control of food: results from the KICk-OFF randomised controlled trial

Price K

KICk-OFF is a 5 days structured education course for 11–16 years old with type 1 diabetes. It has been developed with input from school teachers, children and families and follows constructivist learning theory. A pilot study resulted in some changes to the curriculum.From 2008–2013 a cluster randomised controlled trial, funded by Diabetes UK, has been undertaken, involving 396 participants from 31 UK NHS diabetes centres. Centres were randomis...

ea0017s10 | (1) | BSPED2008

Educational strategies for type 1 diabetes management

Price K

We have been issued with the challenge of delivering structured education to our children and families, with much guidance on the standards we should be aiming to achieve. However translating that into effective educational packages that can be delivered by all centres is challenging, especially when operating within the constraints of staff resources, the need to deliver a clinical service and the lack of ‘teacher training’ opportunities for paediatric teams.<p ...

ea0005s43 | Management of Craniopharyngioma | BES2003

Quality of survival and prognosis for children with craniopharyngioma

Price D

The low incidence of new cases of craniopharyngioma, 1-2 per million per year, and the great variability of morbidity at presentation, have made the evaluation of optimal tumour management extremely difficult. Two patterns of management have evolved over the last 3 decades, namely the performance of 'definitive' radical surgery at onset followed by the use of irradiation to deal with any later recurrence and subtotal tumour resection at onset followed by early irradiation to p...

ea0062p50 | Poster Presentations | EU2019

Nature’s price for Cushing’s disease: A blind eye and a hole in the (pituitary) Middle

Sullivan Heather , Westall Sam , McNulty Sid , Furlong Niall , Gilkes Catherine , Daousi Christina , Narayanan Prakash

Case history: A 61 year old male with a background of diabetes mellitus Type 2 and congestive cardiac failure (CCF) was diagnosed with Cushing’s disease in 2014 following identification of severe osteoporosis through investigations for non-traumatic vertebral fractures causing paraplegia.Investigations: He had high ACTH and cortisol levels which failed to suppress on low and high dose dexamethasone suppression tests, hypogonadotrophic hypogonadism a...

ea0044ep113 | (1) | SFEBES2016

A big price for a little mistake: similar presentations but diverse management of thyroid storm

Iftikhar Mawara , Crown Anna

Introduction: Thyroid storm is a rare endocrine emergency associated with the reported mortality rate ranging from 10 to 20%. We discussed the management of two cases of thyroid storm with different outcomes. It also showed the successful use of ECMO in the management of severe hyperthyroidism related cardiomyopathy and circulatory collapse.Case History 1: A 36 years old female with known history of Graves’ disease, presented with palpitations and s...

ea0050mc2.1 | Masterclass 2: Delivery of specialist endocrine care | SFEBES2017

Neuroendocrine tumours and the set up in the UK

Newell-Price John

Patients with neuroendocrine tumours require co-ordinated multidisciplinary and multimodal management, with appropriate referral pathways and access to timely expert care. This is exemplified by the European Neuroendocrine Tumour Society (ENETS) Centres of Excellence (CoE). There are forty CoE in Europe, ten of which are in the UK. The bar to achieve CoE status is set high, and the standards used for the audit assessments are appropriate to deliver best care even where centre ...